Chicago Equity Partners LLC cut its position in shares of Waters Co. (NYSE:WAT) by 62.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,135 shares of the medical instruments supplier’s stock after selling 10,305 shares during the quarter. Chicago Equity Partners LLC’s holdings in Waters were worth $1,185,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its holdings in Waters by 0.7% during the second quarter. Dimensional Fund Advisors LP now owns 209,081 shares of the medical instruments supplier’s stock worth $38,436,000 after purchasing an additional 1,448 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in Waters during the third quarter worth about $3,446,000. Advisory Services Network LLC boosted its holdings in Waters by 6.0% during the second quarter. Advisory Services Network LLC now owns 1,145 shares of the medical instruments supplier’s stock worth $210,000 after purchasing an additional 65 shares during the last quarter. Nippon Life Insurance Co. purchased a new position in Waters during the third quarter worth about $819,000. Finally, BNP Paribas Arbitrage SA boosted its holdings in Waters by 46.8% during the third quarter. BNP Paribas Arbitrage SA now owns 54,218 shares of the medical instruments supplier’s stock worth $9,733,000 after purchasing an additional 17,280 shares during the last quarter. Institutional investors and hedge funds own 91.88% of the company’s stock.
In other news, SVP Elizabeth B. Rae sold 28,400 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $219.01, for a total value of $6,219,884.00. Following the sale, the senior vice president now owns 13,443 shares of the company’s stock, valued at $2,944,151.43. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Eugene G. Cassis sold 23,863 shares of the business’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $197.53, for a total transaction of $4,713,658.39. Following the completion of the sale, the senior vice president now directly owns 15,100 shares in the company, valued at approximately $2,982,703. The disclosure for this sale can be found here. Over the last quarter, insiders sold 124,789 shares of company stock worth $26,083,647. Corporate insiders own 5.07% of the company’s stock.
Waters (NYSE:WAT) last released its earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.07. The firm had revenue of $687.28 million for the quarter, compared to analysts’ expectations of $671.98 million. Waters had a net margin of 0.88% and a return on equity of 24.70%. The company’s quarterly revenue was up 9.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.21 earnings per share. equities research analysts anticipate that Waters Co. will post 8.16 EPS for the current year.
Several research analysts recently weighed in on the stock. BTIG Research restated a “buy” rating on shares of Waters in a report on Thursday, January 25th. JPMorgan Chase & Co. boosted their price target on shares of Waters from $180.00 to $200.00 and gave the stock a “neutral” rating in a report on Wednesday, January 24th. William Blair restated an “outperform” rating on shares of Waters in a report on Tuesday, January 23rd. Citigroup boosted their price target on shares of Waters from $190.00 to $223.00 and gave the stock a “neutral” rating in a report on Wednesday, January 24th. Finally, Barclays boosted their price target on shares of Waters from $202.00 to $208.00 and gave the stock an “equal weight” rating in a report on Wednesday, January 24th. Twelve research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Waters currently has a consensus rating of “Hold” and an average price target of $203.75.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.